T1D Immunology Medical Science Liaison, Philadelphia, PA

Job Title: T1D Immunology Medical Science Liaison, Philadelphia, PA

Location: Remote/Field

About the Job

The T1D Immunology Medical Science Liaison will play a critical role in helping drive scientific and medical innovation to support Sanofi's autoimmune T1D (aT1D) portfolio and enhance patient outcomes. Reporting to the T1D Immunology Field Medical Director, this role will be responsible for the creation of impactful account plans and for execution of the medical activities and development of KOLs within the designated geography.

Across the aT1D geographies and our ‘one team, common goals, single mission’ approach, this role will be expected to hone a deep understanding of our aT1D stakeholders and their needs, strategically developing and co-creating tailored solutions to meet those needs.

We are an innovative global healthcare company with a focus on immunology that extends to innovation in diabetes and transplant medicine. Across different countries, our talented teams are determined to deliver a best-in-class customer experience using the best of digital, artificial intelligence and personal know-how. With a focus on immunology that extends to innovation in diabetes and transplant medicines, we pursue progress to make a real impact on millions of patients around the world.

Main Responsibilities:

• Build and gain approval for account-specific, ecosystem-strategic plans pertaining to teplizumab and the aT1D portfolio.

• Continuously update medical account plans with a combined business and scientific mindset.

• Collaborate closely with the Field Medical Director to co-create robust, impactful plans for the key accounts that reflect the Medical Affairs strategic imperatives and anticipate pre- and peri-launch needs.

• Collaborate closely with cross-functional matrix teams and integrate medical insights into commercial strategies and patient support programs.

• Demonstrate medical solution-finding and value within the matrix team; active involvement and engagement during matrix meetings.

• Continuous engagement in key accounts to create clinical value and demonstrated impact through exceptional/innovative field medical results and perception metrics

• Develop and broaden a network of developing KOLs for peer-to-peer engagement within targeted medical accounts.

• Expand reach to engage identified primary care healthcare professionals to increase awareness and acceptance of screening, staging, and monitoring of early stage T1D within their practices.

• Collaborate with public health strategy specialist colleagues to share insights and accelerate expansion of T1D screening and monitoring awareness and implementation within key accounts and geographies

• Compliantly support educational events with Public Health or Commercial, within the local communities

• Collaborate with Corporate Affairs in educational events with PAGs or within the patient community, including medical-led T1D screening events per global standards

• Execute local congress plans including medical-led T1D screening events per global standards

• Prioritize Identification of suitable clinical trial and registry sites and provide comprehensive support throughout the trial timelines.

• Gain deep insights into the medical needs and priorities of key medical accounts using and interpreting RW data, contributing to Sanofi’s account planning and orchestrating medical engagement, to drive impact on screening and monitoring to improve outcomes.

• Establish and cultivate scientific partnerships within the aT1D community to foster collaboration and enhance medical support efforts.

• Enhance medical awareness among healthcare providers regarding significant medical discoveries and practice trends in Sanofi’s aT1D portfolio and pipeline through educational initiatives, including communicating the important outcomes data related to Sanofi products.

• Facilitate constructive dialogue among HCPs about aT1D to promote knowledge exchange and best practices in patient screening and care.

• Demonstrated accountability in timely documentation of insights, activities, and strategic wins of ecosystem medical plans in CRM.

• Stay updated on emerging scientific and technological advances and regulatory requirements in T1D immunology to inform strategic decision-making.

• Cultivate a culture of scientific excellence and uphold ethical standards among teams, fostering continuous learning and professional growth.

• Communicate the benefits, risks, appropriate use, and clinical value of our products and solutions in an accurate, fair, and balanced manner.